Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Diagnostic Codes

ICD-10 Code M31.8: Other specified necrotizing vasculopathies

Key Takeaways

Key Takeaways

ICD-10 Code M31.8 describes other specified necrotizing vasculopathies, a billable ICD-10-CM diagnosis code valid for FY2026 submissions.

Use M31.8 when documentation identifies a specific necrotizing vasculopathy that does not fit any named subcategory in the M31 block (M31.0 through M31.7).

M31.8 differs from M31.9 (unspecified): M31.9 applies only when the vasculopathy cannot be further specified; M31.8 requires the clinician to name the condition.

Pabau’s claims management software helps rheumatology and specialty practices track diagnostic code submissions and reduce denials tied to unspecified code selection.

ICD-10 Code M31.8: definition and billable status

ICD-10 Code M31.8 is a billable ICD-10 diagnosis code used to document other specified necrotizing vasculopathies. It falls under category M31 (Other necrotizing vasculopathies), within chapter M00-M99 (Diseases of the musculoskeletal system and connective tissue). According to the CMS ICD-10 codes page, M31.8 is valid and billable for fiscal year 2026.

Coders reach for M31.8 when clinical documentation identifies a specific necrotizing vasculopathy that does not match any named condition within M31.0 through M31.7. The “other specified” designation means the condition is documented but does not map to a more granular ICD-10-CM code in the same block.

Code details at a glance

The table below summarises key administrative facts for ICD-10 Code M31.8 as published in the FY2026 ICD-10-CM tabular list.

Field Detail
Code M31.8
Description Other specified necrotizing vasculopathies
Billable / Valid Yes – valid for claim submission
FY Effective FY2026 (October 1, 2025 – September 30, 2026)
Chapter M00-M99: Diseases of the musculoskeletal system and connective tissue
Block / Category M30-M36 / M31 Other necrotizing vasculopathies
Code Type Diagnosis (ICD-10-CM)
Code Set ICD-10-CM (US clinical modification)

As the WHO ICD-10 browser confirms, the M31 category sits within the systemic connective tissue disorders block (M30-M36). The ICD-10-CM maintains the same hierarchical position with US-specific clinical modifications applied by the CDC NCHS and mandated under HIPAA for all covered entities.

What does M31.8 mean clinically?

Necrotizing vasculopathies are a group of disorders characterised by inflammation and destruction of blood vessel walls, leading to tissue ischaemia and necrosis. M31.8 captures cases where the pathology is documented by the treating clinician but does not meet the criteria for any specifically named condition within the M31 block.

In practice, rheumatologists and internists encounter patients whose biopsy or clinical findings confirm necrotizing vascular damage without a clear match to polyarteritis nodosa (M30.0), Wegener’s granulomatosis (M31.3x), or other named entities. M31.8 is the appropriate code for those cases, provided the documentation specifies the condition rather than leaving it open-ended. Proper patient records are essential for supporting this specificity.

Comprehensive patient records
Comprehensive patient records

Conditions that may map to M31.8 include, but are not limited to:

  • Necrotizing vasculitis affecting small or medium vessels, documented specifically but not matching a named M31 subcategory
  • Autoimmune vasculopathy with necrosis, confirmed on biopsy, without further classification
  • Hypocomplementaemic urticarial vasculitis with documented necrotizing features
  • Drug-induced necrotizing vasculitis with a specified causative agent documented in the record
  • Isolated cutaneous necrotizing vasculitis with systemic features noted but not meeting criteria for systemic vasculitis codes

The key clinical documentation requirement is that the treating physician has named or described a specific vasculopathy. Without that specificity, coders must default to M31.9 (unspecified). Accurate medical forms and clinical documentation at point of care prevents downstream coding ambiguity.

Synonyms and alternate names for M31.8

The ICD-10-CM alphabetic index includes several entry paths that lead coders to M31.8. Knowing these synonyms helps when documentation uses terminology different from the official code description.

  • Other specified necrotizing vasculopathy
  • Necrotizing vasculopathy NOS (specified type)
  • Specified necrotizing angiitis
  • Necrotizing vasculitis, specified NEC
  • Autoimmune necrotizing vasculopathy, specified type
  • Ischaemic vasculopathy with necrosis, specified

When a pathology report or rheumatology note uses any of these terms with a named descriptor, M31.8 is the correct code selection over the unspecified alternative. The AAPC Codify ICD-10-CM lookup and the ICD List reference database both catalogue these synonyms against M31.8.

ICD-10 Code M31.8 in the M31 hierarchy: category M31 codes

Understanding where M31.8 sits within the M31 block helps coders identify whether a more specific code applies. The full M31 category covers other necrotizing vasculopathies, with each subcategory describing a distinct named condition. M31.8 is the residual “other specified” slot before the catch-all M31.9.

Code Description Billable
M31.0 Hypersensitivity angiitis (Goodpasture’s syndrome) Yes
M31.1 Thrombotic microangiopathy (TTP) Yes
M31.2 Lethal midline granuloma Yes
M31.3x Wegener’s granulomatosis (with/without renal involvement) Yes (subcodes)
M31.4 Aortic arch syndrome (Takayasu’s disease) Yes
M31.5 Giant cell arteritis with polymyalgia rheumatica Yes
M31.6 Other giant cell arteritis Yes
M31.7 Microscopic polyangiitis Yes
M31.8 Other specified necrotizing vasculopathies Yes
M31.9 Necrotizing vasculopathy, unspecified Yes

Coders should work through M31.0 through M31.7 before reaching M31.8. If the documented condition matches a named subcategory, that more specific code takes priority. M31.8 applies only when the condition is named or described but falls outside the existing named entries. The CDC/NCHS ICD-10-CM web tool provides the official tabular list to confirm these hierarchical relationships for any fiscal year.

Pro Tip

Before coding M31.8, run through the full M31 code range sequentially. Document in the coding rationale why each named subcategory (M31.0 through M31.7) does not apply. This protects the claim during audit and demonstrates medical necessity for the specificity level chosen.

M31.8 vs M31.9: choosing the right necrotizing vasculopathy code

This is where most coding errors occur. The distinction between M31.8 and M31.9 is not about the severity of the condition. It is about the specificity of the clinical documentation.

Factor M31.8 (Other specified) M31.9 (Unspecified)
Documentation Clinician names or describes the specific vasculopathy Documentation does not specify the type
Specificity Condition identified, but no named M31 subcategory exists for it Type cannot be further determined from available information
Payer preference Preferred: demonstrates clinical specificity May trigger medical necessity queries from payers
Coder action Use when documentation names a condition outside M31.0-M31.7 Use only as last resort when querying the physician would be impractical
Query guidance No query needed if condition is named in the note Consider querying physician to clarify if specificity can be added

A practical decision rule: if the physician’s note says “necrotizing vasculitis consistent with hypocomplementaemic urticarial vasculitis,” use M31.8 because the condition has been named and it does not have its own M31 code. If the note says “necrotizing vasculopathy, type unclear, further workup pending,” use M31.9 and consider a physician query before finalising the claim. See how specificity works across other ICD-10 diagnostic code families for comparison.

Coding guidelines and documentation requirements for M31.8

The ICD-10-CM Official Guidelines for Coding and Reporting, maintained by the CDC NCHS and CMS, govern how coders apply M31.8. Several rules bear directly on this code.

Use of “other specified” codes

ICD-10-CM coding guidelines require coders to assign the highest level of specificity supported by the medical record. “Other specified” codes like M31.8 are appropriate when the clinical documentation identifies a specific condition, but the classification does not provide a unique code for it. Coders should not assign M31.8 based on their own clinical judgment about what the condition might be.

Under HIPAA compliance requirements, covered entities must use ICD-10-CM codes that accurately reflect the documented diagnosis. Selecting M31.9 when M31.8 is supportable may expose the claim to denial on the basis of insufficient specificity. Practices using compliance management software can flag code selection patterns that default to unspecified codes without documented rationale.

HIPAA compliance in Pabau
HIPAA compliance in Pabau

Additional code requirements

No mandatory additional codes are required with M31.8. However, coders should consider:

  • An external cause code if the vasculopathy is drug-induced (e.g., a T-code from the adverse effects table)
  • Organ-specific manifestation codes if appropriate (e.g., renal involvement may warrant an additional code from N00-N29)
  • Codes for associated conditions such as ANCA-associated markers or autoimmune serology findings, where a specific code exists

Excludes and includes notes

The M31 category includes conditions previously classified as polyarteritis nodosa and related conditions in ICD-9. Coders should verify there are no Excludes1 or Excludes2 notes at the M31 category level that apply to the specific condition being coded. The digital documentation tools a practice uses should capture the treating physician’s exact terminology, which is the foundation for accurate code selection.

Digital forms
Digital forms

Reduce diagnostic coding errors with Pabau

Pabau's claims management and compliance tools help specialty and rheumatology practices track ICD-10 code submissions, identify unspecified code patterns, and build documentation workflows that support audit-ready claims.

Pabau practice management platform

ICD-10-CM index references for ICD-10 Code M31.8

The alphabetic index in the ICD-10-CM provides multiple entry paths to reach M31.8. Coders who are unfamiliar with the code but know the condition name can use these index routes to verify their selection.

  • Vasculopathy, necrotizing → see Vasculopathy, necrotizing (M31.-) → other specified → M31.8
  • Vasculitis, necrotizing → NEC → M31.8
  • Angiitis → necrotizing → specified type NEC → M31.8
  • Vasculopathy → autoimmune, specified NEC → M31.8

Index routes can vary slightly by ICD-10-CM edition year. Always verify against the current year’s official index before finalising a code. The same principle applies across other specified diagnostic codes in psychiatry and neurology, where index routes sometimes differ from intuitive code pathways.

Code history and FY2026 validity

ICD-10 Code M31.8 has been a stable entry in the ICD-10-CM tabular list since the US adoption of ICD-10-CM. The code has not undergone significant revisions in recent fiscal years and is confirmed valid for FY2026 (effective October 1, 2025). No new additions within the M31 block for FY2026 affect the scope of M31.8.

Coders should check the CMS annual ICD-10-CM update files each October to confirm that no new named vasculopathy codes have been added to M31.x that would narrow the scope of M31.8 for the new fiscal year. Conditions that previously mapped to M31.8 may receive their own dedicated codes in future updates. Practices relying on claims management software can configure alerts for annual code set changes affecting active diagnosis codes.

The secure handling of patient diagnostic data is equally important when managing records tied to rare conditions like necrotizing vasculopathies, where small patient populations can make re-identification risks higher than average. Practices should review their data governance policies alongside annual code updates. Use practice management software that maintains an auditable record of code selection decisions across encounters.

Pro Tip

Set a recurring calendar reminder for October 1 each year to check the CMS ICD-10-CM addenda for any new M31.x codes. If a new named vasculopathy code is added, any existing claims coded as M31.8 for that condition from the new FY onwards will need to be updated to the more specific code.

Continue your research

Continue your research

Need to understand how ICD-10 diagnostic codes work across conditions? Intraparenchymal hemorrhage ICD-10 codes walks through code selection, specificity rules, and related code navigation for another complex diagnosis category.

Looking to reduce unspecified code denials across your specialty practice? Pabau’s claims management software helps practices track submission patterns and flag unspecified code usage before claims leave the practice.

Want to see how rheumatology and specialty clinics manage compliance documentation? Pabau for skin and dermatology clinics covers documentation workflows for connective tissue and inflammatory skin conditions.

Conclusion

Coding errors on M31.8 typically come from one of two places: defaulting to M31.9 when the physician has documented a specific condition, or assigning M31.8 when a more precise named code (M31.0 through M31.7) actually applies. Both errors are preventable with a clear documentation workflow at the point of care.

Pabau’s digital forms and structured clinical documentation tools help specialty practices capture the precise terminology that supports accurate ICD-10 Code M31.8 assignment, reducing the back-and-forth between coders and clinicians at claims time. To see how Pabau handles diagnostic documentation and claims tracking for specialty practices, book a demo.

Frequently Asked Questions

What is ICD-10 Code M31.8?

ICD-10 Code M31.8 is a billable ICD-10-CM diagnosis code for other specified necrotizing vasculopathies. It applies when clinical documentation identifies a specific necrotizing vasculopathy that does not fit a named subcategory within the M31 block (M31.0 through M31.7). The code is valid for FY2026 submissions under the CMS ICD-10-CM tabular list.

Is M31.8 a billable ICD-10-CM code?

Yes. M31.8 is a billable ICD-10-CM diagnosis code, valid for claim submission for fiscal year 2026 (October 1, 2025 through September 30, 2026). It is confirmed billable by the CMS ICD-10-CM tabular list and multiple authoritative code references.

What is the difference between M31.8 and M31.9?

M31.8 applies when the clinician has documented a specific necrotizing vasculopathy that does not match a named subcategory (M31.0 through M31.7). M31.9 is for unspecified necrotizing vasculopathy, used only when the type cannot be further determined from the available clinical documentation. Payers generally prefer M31.8 when documentation supports it.

What conditions are classified under M31 necrotizing vasculopathies?

The M31 category includes hypersensitivity angiitis (M31.0), thrombotic microangiopathy (M31.1), lethal midline granuloma (M31.2), Wegener’s granulomatosis (M31.3x), Takayasu’s disease (M31.4), giant cell arteritis with polymyalgia rheumatica (M31.5), other giant cell arteritis (M31.6), microscopic polyangiitis (M31.7), other specified necrotizing vasculopathies (M31.8), and unspecified necrotizing vasculopathy (M31.9).

Which ICD-10 vasculitis codes are related to M31.8?

Closely related ICD-10 vasculitis codes include M30.0 (polyarteritis nodosa), M30.1 (polyarteritis with lung involvement), M31.3x (Wegener’s granulomatosis), and M31.7 (microscopic polyangiitis). Within the M31 block, M31.9 is the direct sibling for unspecified cases. Coders should review the full M30-M36 block when necrotizing vascular pathology involves systemic connective tissue conditions.

Is ICD-10 Code M31.8 valid for 2026 submissions?

Yes. ICD-10 Code M31.8 is valid for FY2026 submissions, effective October 1, 2025. The code has not been revised or deleted in the FY2026 ICD-10-CM update cycle. Verify against the annual CMS addenda each October to confirm continued validity in future fiscal years.

×